Editorial: Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment

Front Immunol. 2023 Sep 18:14:1283186. doi: 10.3389/fimmu.2023.1283186. eCollection 2023.

¹ Pharmaceutical Research and Early Development Oncology, Roche Innovation Center Zurich, F. Hoffmann-La Roche AG, Zurich, Switzerland.
² Pharmaceutical Research and Early Development Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Basel, Switzerland.
³ Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University Cancer Centre, Lund University, Lund, Sweden.
⁴ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Keywords: biomarkers; cancer; checkpoint blockade; fibroblasts; imaging; immune oncology; immunotherapy; tumor microenvironment.

Publication types